AIM ImmunoTech Inc.

Emerging immunotherapy technologies are transforming treatment for gastrointestinal cancers, with companies developing novel combination strategies to activate immune responses in historically resistant tumors. The global cancer immunotherapy market is projected to reach $443.17 billion by 2030.

AIM ImmunoTech reported positive mid-year data for Ampligen in pancreatic cancer treatment, combining with AstraZeneca's Imfinzi, and raised $8 million in a public equity offering to fund operations for approximately 12 months.

Penny stocks to watch with news that are turning heads in the stock market this week. The post 5 Penny Stocks To Watch After Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.